Products/Services Used | Details | Operation |
---|---|---|
Peptide Synthesis> | dynein intermediate chain (sc13524) and Rab18 (sc393168) were purchased from Santa Cruz Biotechnology; AKT (4691P), pAKT (4060S), CREB (9197S), pCREB (9198S), and EEA1 (2411S) antibodies were purchased from Cell Signaling Technology; PLD1 (A15081) was purchased from Abclonal; GM130 (610822) and PDI (612117) were purchased from BD Bioscience; and Golgin97 (A21270) was purchased from Life Technologies. An affinity-purified rabbit polyclonal antibody was raised against the peptide CDKNRVPYVKGCTER (rat KIF5c amino acids 159–172) by GenScript. | Get A Quote |
Triglyceride-rich lipid droplets (LDs) are catabolized with high efficiency in hepatocytes to supply fatty acids for producing lipoprotein particles. Fasting causes a massive influx of adipose-derived fatty acids into the liver. The liver in the fasted state is therefore bloated with LDs but, remarkably, still continues to secrete triglycerides at a constant rate. Here we show that insulin signaling elevates phosphatidic acid (PA) dramatically on LDs in the fed state. PA then signals to recruit kinesin-1 motors, which transport LDs to the peripherally located smooth ER inside hepatocytes, where LDs are catabolized to produce lipoproteins. This pathway is down-regulated homeostatically when fasting causes insuli... More